This is why it was sold down and to all those who think deals are imminent and this will rerate march then April etc. You are right it will rerate down again as delay another year
Ann: Updated guidance for PAT-DX1 phase 1 clinical study, page-4
-
- There are more pages in this discussion • 122 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.001(7.14%) |
Mkt cap ! $15.43M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.8¢ | 0.8¢ | $584 | 77.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 3253865 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 2103283 | 10 |
View Market Depth
| Last trade - 12.22pm 19/06/2024 (20 minute delay) ? |
| PAB (ASX) Chart |